Scientists found that COVID-19 effective antibody: patients can bring 6 months of protection after treatment.
researchers said the antibody was isolated from lymphocytes infected with COVID-19 and is one of the most effective anti COVID-19 antibodies identified so far. p>
the structural characteristics of the monoclonal antibody enable it to bind to a region not affected by spike protein mutation. Through this close interaction, the antibody prevents the spike protein from binding to cells expressing ACE2 receptor, which is the receptor for the virus to enter and infect lung cells</ P>
means that antibodies can stop the process of virus replication, so that the patient’s immune system can clear COVID-19 from the body. And this protective mechanism has been proved in animal experiments. Even after receiving high infection dose, animal samples treated with antibody can prevent infection</ P>
is worth mentioning that the new antibody has antiviral properties, and is designed to have a protective effect similar to that of the vaccine. It can protect the patient from being affected by COVID-19 for 4-6 months. p>
this makes it a new preventive treatment option, which is suitable for high-risk groups that are not vaccinated or vaccinated groups that cannot produce immune response. In addition, patients with low immune function, organ transplant recipients and patients with certain cancers can also prevent COVID-19 by injecting two or three times of the antibody each year. p>
at present, scientists are planning to cooperate with a start-up company to carry out the clinical development and production of antibody containing drugs through cooperation and intellectual property agreement, and it is expected to start the clinical trial of the drug by the end of 2022